AU2825100A - Heterocyclic compounds having affinities for serotonin receptors - Google Patents

Heterocyclic compounds having affinities for serotonin receptors

Info

Publication number
AU2825100A
AU2825100A AU28251/00A AU2825100A AU2825100A AU 2825100 A AU2825100 A AU 2825100A AU 28251/00 A AU28251/00 A AU 28251/00A AU 2825100 A AU2825100 A AU 2825100A AU 2825100 A AU2825100 A AU 2825100A
Authority
AU
Australia
Prior art keywords
affinities
heterocyclic compounds
serotonin receptors
serotonin
receptors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU28251/00A
Inventor
Toshiyuki Kamigauchi
Mitsuru Yasui
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Publication of AU2825100A publication Critical patent/AU2825100A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/16—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
AU28251/00A 1999-03-30 2000-03-02 Heterocyclic compounds having affinities for serotonin receptors Abandoned AU2825100A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP8831999 1999-03-30
JP11/88319 1999-03-30
PCT/JP2000/001224 WO2000059909A1 (en) 1999-03-30 2000-03-02 Heterocyclic compounds having affinities for serotonin receptors

Publications (1)

Publication Number Publication Date
AU2825100A true AU2825100A (en) 2000-10-23

Family

ID=13939615

Family Applications (1)

Application Number Title Priority Date Filing Date
AU28251/00A Abandoned AU2825100A (en) 1999-03-30 2000-03-02 Heterocyclic compounds having affinities for serotonin receptors

Country Status (2)

Country Link
AU (1) AU2825100A (en)
WO (1) WO2000059909A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001286259A1 (en) * 2000-09-22 2002-04-02 Shionogi And Co., Ltd. Tricyclic indole compounds having affinity for serotonin receptor
US10966959B2 (en) 2018-06-19 2021-04-06 Wisconsin Alumni Research Foundation Use of a rotifer-derived compound and its analogs for preventing schistosomiasis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9407637D0 (en) * 1994-04-18 1994-06-08 Erba Carlo Spa Serotoninergic abeo-ergoline derivatives
JPH11503757A (en) * 1995-04-18 1999-03-30 イーライ・リリー・アンド・カンパニー Use of ergoline compounds that produce physiological and pathological functions at 5-HT (7) receptors

Also Published As

Publication number Publication date
WO2000059909A1 (en) 2000-10-12

Similar Documents

Publication Publication Date Title
GB9929973D0 (en) Heterocyclic compounds
AU3764300A (en) Invertebrate biogenic amine receptors
AU1978699A (en) Heterocyclic compounds
AUPP818099A0 (en) New n-containing heterocyclic compounds
PL356990A1 (en) Isoxazolecarboxamide derivatives as alpha1-adrenergic receptor antagonists
AU5633300A (en) Indole compounds
AU2399401A (en) Spiro compounds useful as opioid delta receptor agonist
PL350234A1 (en) Heterocyclic benzenesulphonamide compounds as bradykinine antagonists
IL148623A0 (en) Thienoisoxazolyl-and thienylpyrazolyl-phenoxy substituted propyl derivatives useful as d4 antagonists
AU2002232468A1 (en) Pharmaceutical heterocyclic compounds
EP1146871A4 (en) Antidepressant heterocyclic compounds
AU2001258841A1 (en) Heterocyclic compounds
MXPA00011504A (en) Substituted heterocyclic derivatives.
AU2001259051A1 (en) Piperidyindoles as serotonin receptor ligands
AU1339301A (en) Novel indole compounds
AUPP921299A0 (en) New heterocyclic compounds
AU2825100A (en) Heterocyclic compounds having affinities for serotonin receptors
AU3670900A (en) Substituted fused imidazole derivatives
AU1100300A (en) Piperidyloxadiazoles as dopamine receptor antagonists
AU5887400A (en) Derivative compounds
AU2663100A (en) Substituted aryl heterocyclic compounds
IL144810A0 (en) Dopamine d1 receptor agonist compounds
AU2003297408A1 (en) Thiazole compounds as integrin receptor antagonists derivatives
IL150010A0 (en) Heterocyclic derivatives
AU2356301A (en) Silylated heterocyclic compounds

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase